|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
9 `6 ^" e/ V# b& Z. A6 ?" c4 p4 J01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.
: K/ _9 W t0 y+ {8 j02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ h) c! e9 u2 `9 | m
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.. I, |) N5 i8 R# f) I* h( q
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
# B/ n6 ]1 c6 S V% e6 `+ \) [05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study./ a4 H; f, a+ C1 }2 |6 n
06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.
2 O J1 m/ A' k0 F5 s( |8 W+ J1 V07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.) k# N( o" `/ f! x$ S, @8 b
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.
# W. R s7 L6 G, E( z09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.3 `1 Q; Y* ~7 x' [( h
10.Interpretable machine learning for prostate biopsy: Cohort study.
" g$ I, N6 K. R11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.
+ o# x m5 W5 F* d% j- m( \! |12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report." u( y r9 r& h' n0 \4 D. h3 n' G6 I
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).
& ~" m' x) a A+ U& A( W) L14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).2 k! K7 A6 K4 d
15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy. ~+ |, o$ l9 G: i5 S
16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
) G6 a4 [* Y3 d; m1 S, a6 w17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.+ A. ~! s& `5 C. _# f2 \1 \6 s
18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.* e4 Y4 d4 [1 |" ^4 G) N& y. @% M
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.
; n3 J2 W$ I( F20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
& H+ Z8 t- V6 L* G. ]3 W21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
* p. y% I# j' a) h8 f& Q0 \. ^0 Q22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis.
1 D( N# o. Y% c ^! A) V23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.4 G5 t$ }) o# ^' p' Y- G, E
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.0 B9 ~! e8 c( c( E5 T1 ]
25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.& N# @& A) n- i; b3 `( t1 h
|
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶